Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presented its technology platform for treating diuretic-resistant fluid overload in liver disease, malignant ascites, and heart failure. The presentation covers the alfapump® system, which was under clinical investigation in the POSEIDON Study, and DSR® therapy in development. The company is addressing significant unmet medical needs in fluid management across multiple therapeutic areas.
conference
21 Pages
Thoughtworks Holding, Inc.
investor_presentation
Antilles Gold Limited